Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting (NCT01492569) | Clinical Trial Compass
WithdrawnNot Applicable
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
Stopped: low accrual
United States0Started 2012-05
Plain-language summary
This randomized pilot clinical trial studies giving acupuncture in reducing nausea and vomiting in patients undergoing chemotherapy. Pressing and stimulating nerves at an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy.
Who can participate
Age range8 Years – 21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient with a planned admission for at least 24 hours for highly emetogenic or moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard El Camino.
* Planned to undergo at least 2 more cycles of chemotherapy.
* Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma, Osteosarcoma
* History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at minimum) despite use of conventional antiemetic medications.
* Age 8-21.
* Parent must be able to understand and willing to sign written informed consent document.
Exclusion Criteria:
* Prior knowledge of acupuncture or experience with acupuncture or acupressure.
* There will be no restrictions regarding use of other Investigational Agents.
* Comorbid Diseases:
* Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker placement).
* Any diagnosis requiring pediatric intensive care unit admission.
* Patients with brain tumor, brain metastasis (these patients often require radiation and surgery in addition to chemotherapy which may confound the results)
* Concomitant radiation therapy during current chemotherapy cycle.
* Developmental delay patients with allergy to tape or leads will be excluded from the study.
* Pregnant patients will be excluded from the study.
* Cancer survivors will not be excluded from the study as long as they are undergoing chemotherapy treatment for their current cancer therapy.
* HIV-positive …
What they're measuring
1
Number of episodes of vomiting
Timeframe: During the first 24 hours of chemotherapy
2
Severity of nausea as recorded on the visual analogue scale (VAS)
Timeframe: During the first 24 hours of chemotherapy